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Abstract: This study was carried out to reveal the importance of procalcitonin, C reactive protein, nitric oxide levels, and adenosine
deaminase activity in the diagnosis and prognosis of the disease in naturally infected sheep with Babesia ovis. Thirty sheep diagnosed
clinically and parasitologically as having Babesia ovis were allocated to 2 groups. The first group was treated only with imidocarp
dipropionate and the second group with imidocarp dipropionate and flunixine meglumin. On the seventh day after treatment, blood
samples were collected again from the sheep in the babesiosis-infected group and the treatment responses were assessed. Serum PCT
(1.72 ± 0.34 ng/mL, P < 0.01), CRP (101.42 ± 11.73 µg/mL, P < 0.001), NO (15.77 ± 2.75 µmol/L, P < 0.01), and ADA (13.92 ± 0.88
IU/L, P < 0.01) were higher in sheep with babesiosis than in the healthy sheep (0.49 ± 0.04 ng/mL, 49.46 ± 4.57 µg/mL, 8.15 ± 0.63
µmol/L, 9.34 ± 1.19 IU/L, respectively). When PCT, CRP, NO, and ADA before treatment and after treatment in the infected sheep were
compared, the levels of these parameters except for ADA in the second group were determined to have statistically decreased after the
treatment. As a result, it has been concluded that the measurements of PCT, CRP, NO, and ADA in sheep with babesiosis may be useful
for the diagnosis and prognosis of the disease when assessed in association with clinical examination.
Key words: Babesia ovis, PCT, CRP, NO, ADA

1. Introduction
Babesiosis is a hemoparasitic disease transmitted by ticks
and it causes significant economic losses (1). Babesia
ovis, B. motasi, B. crassa, and B. foliata are seen in sheep
(2). Symptoms such as fever, anemia, hepatitis, and
hemoglobinuria are observed in Babesia ovis infection,
and it can result in death in certain cases (3).
Procalcitonin (PCT) is a prohormone of the hormone
calcitonin. It is composed of 116 amino acids and lacks
hormonal activity (4,5). It is ubiquitous and produced
in the C cells (parafollicular cells) of the thyroid gland
(6). PCT production is regulated physiologically and
pathologically by the calcitonin-1 (CALC-1) gene located
on chromosome 11 (7). PCT is increased in bacterial,
parasitic, and fungal infections with severe systemic
findings and sepsis, although it never increases in viral
infections (4,8–10). In the presence of a microbial
infection, CALC-1 gene expression is increased, which
triggers PCT production in all parenchymal tissues

(including liver, lung, kidney, adipocytes, and muscle)
and differentiated cells in the body (11). Studies have
shown that PCT levels are high in the patients with
malaria (9,10). As with malaria caused by Plasmodium
falciparum, babesiosis can also be classified as protozoal
sepsis (12). In another study, significant differences in PCT
levels were found between healthy dogs and dogs with
babesiosis (13). It is stated that PCT has a diagnostic and
prognostic value, and may also help to assess therapeutic
efficacy, as it increases in accordance with the severity
of the inflammatory response to the infection (4). It has
been stated that the prognosis of patients whose PCT
levels continuously increase is poor, and the prognosis of
patients whose PCT levels decrease rapidly is good (14).
CRP is an acute phase protein synthesized in the liver; it
increases in a way similar to PCT in infections, and is a
biomarker that is also used to monitor the progress of the
disease. Unlike PCT, CRP levels can also increase in slight
inflammatory reactions and viral infections (15).

* Correspondence: sezaivetgov@yahoo.com

512

This work is licensed under a Creative Commons Attribution 4.0 International License.

ARSLAN et al. / Turk J Vet Anim Sci
ADA is an enzyme that catalyzes the conversion of
adenosine into inosine (16). ADA activity is elevated in
many diseases that are stimulated by cellular immunity
(17). NO, which is an important mediator of physiological
and pathophysiological events, is produced mostly in
macrophages, neutrophils, and mast cells (18).
LPS and IFN-γ-stimulated macrophages induce
cytostatic and/or cytotoxic effects against bacteria,
parasites, and tumor cells by producing a large amount of
NO (19). Regarding babesiosis in bovines, NO, ADA, and
TNF-α levels are reported to be significantly increased,
and to be sensitive parameters in predicting the diagnosis
and prognosis of the disease (17).
Although many parameters are used in the diagnosis of
babesiosis and in the prediction of its prognosis, no study
has reported the importance of PCT as a biomarker in the
prognosis and diagnosis of the pre- and post-treatment
phases of naturally occurring babesiosis in sheep. The
aims of this study were to determine the value of PCT as a
biomarker in naturally occurring babesiosis in sheep and
also to determine its relationship with other parameters
(i.e., NO, ADA, CRP) used for this particular disease.
2. Materials and methods
2.1. Animals and treatment
The animal material of this study consisted of 45
Akkaraman breed sheep with an average of 30–40 kg live
weight and 3–4 years of age in the Van Province region
between June and July 2016. The diagnoses were made with
clinical and laboratory findings; 30 were naturally infected
with Babesia ovis and 15 were healthy. The babesiosisdiagnosed sheeps were divided into 2 groups according
to the treatment administered. Imidocarb dipropionate
(1.2 mg/kg/bw) treatment was administered to the first
group (G1), and imidocarb dipropionate (1.2 mg/kg/bw,
IM) and flunixin meglumine (2.2 mg/kg/bw, IM, 2× with
a 24 h interval) combined treatment was administered to
the second group. Blood samples were taken from the V.
jugularis of the infected sheep in the usual manner before
the treatment (BT) and on day 7 after the treatment (AT)
for laboratory analysis, using the required method. The
control group consisted of healthy sheep which were found
to be negative according to the results of the laboratory
evaluations in terms of other blood parasites, and which
had no disease history or clinical findings specific to
babesiosis or other diseases, and which had the same
regional and rearing conditions. All the animals used were
kept in their normal environment during the study.
2.2. Diagnosis of babesiosis
The diagnosis of babesiosis was made after the May–
Grünwald/Giemsa staining, with the detection of
parasites in the blood smears. Blood samples brought
to the laboratory in K2EDTA plastic tubes were stored

at –80 °C after immediate centrifugation at 3000 rpm
for 15 min. DNA extraction from blood samples was
performed using a commercially available kit, in
accordance with the instructions for use. A primer couple
was used; the forward primer specific for B. ovis was
5′-ATGTTGGCCAAGTATCTTGCC-3′ and the reverse
primer was 5′-CTACGTCAATTTGGCCTTGAACTC-3′.
PCR analysis was performed as reported by Erster et al.
(20). For the PCR phase, a BioRad T100 model thermal
cycler was used. The amplification product obtained in
the PCR was subjected to electrophoresis in an ethidium
bromide-stained agarose gel to be controlled in terms of
the region of 468 bp belonging to the target gene region.
2.3. Hematological analysis
Complete blood counts (MS4 Hematology, Melet
Schloesing, Osny, France) were performed on the same day
in anticoagulated blood samples (WBC: white blood cell;
LYM: lymphocyte; MON: monocyte; NEU: neutrophil;
EOS: eosinophil; RBC: red blood cell; MCV: mean
corpuscular volume; PCV: packed cell volume; MCH:
mean corpuscular hemoglobin; MCHC: mean corpuscular
hemoglobin concentration; RDW: red distribution width;
HGB: hemoglobin).
2.4. Serum biochemical examinations
Blood samples without anticoagulant were centrifuged at
3000 rpm for 10 min (Rotofix 32, Hettich, Kirchlengern,
Germany) to separate the sera. Serum samples were stored
at –80 °C until all blood samples were collected. The blood
urea nitrogen (BUN), creatine, creatine kinase (CK), total
protein, albumin, glucose, total bilirubin (T-bilurubin),
direct bilurubin (D-bilurubin), and alkaline phosphatase
(ALP) levels were measured in serum samples using a
biochemical analyzer device (BS-120, Mindray, Shenzhen,
China) after all blood samples were collected. PCT, total
NO, ADA (all 3, MyBioSource, San Diego, CA, USA), and
CRP (Cusabio, Houston, TX, USA) levels were measured
with a microplate spectrophotometer (Epoch, BioTek,
Winooski, VT, USA) with sheep-specific ELISA test kits.
2.5. Statistical analyses
For the preparation of statistical data, the SPSS 24 statistical
program pack was used. Parameters are given as mean ±
SEM. A normality test was performed with a Kolmogorov–
Smirnov test. Independent samples and paired-samples
t-tests were used for normal distribution samples, and the
Mann–Whitney U test and Wilcoxon test were used for
those without normal distribution. The Mann–Whitney U
test and independent-samples t-test were used to compare
the control and babesiosis groups and the differences
between G1 and G2 after the treatment. The paired-sample
t-test and the Wilcoxon test were used to compare G1 and
G2 before and after treatment. P < 0.05 was regarded as
statistically significant. Receiver operating characteristic
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(ROC) curves were drawn for PCT, CRP, NO, and ADA
as a measure of discriminating power between the control
and BT babesiosis groups. The ROC curve shows the
false-positive rate (1 – specificity) and true-positive rate
(sensitivity) of a test. Diagnostic accuracy was assessed
by calculating the areas under the ROC curves (AUC).
Youden’s index (YI) (YI = sensitivity + specificity – 1) was
used to choose the most appropriate cut-off points for
PCT, CRP, NO, and ADA parameters.
3. Results
3.1. Clinical findings
The sheep included in the study showed one or more of the
following clinical findings: depression (30/30), anorexia
(30/30), pale mucous membranes (18/30), fever (25/30),
and hemoglobinuria (25/30). There were no deaths among
the sheep examined and all of them responded to the
treatment positively.
3.2. PCR results
In the PCR analysis, B. ovis was detected in all blood
samples of the sheep with babesiosis.
3.3. PCT, NO, CRP, and ADA results
PCT, NO, and CRP levels and ADA activity were found to
be higher in sheep with BT babesiosis than in healthy sheep,

and this value was found to be statistically significant.
(Table 1). BT PCT, NO, CRP, and ADA values of animals
in G1 and G2 had decreased in AT, and all parameters in
G1 and G2 were statistically significant except for ADA.
No statistical significance was found between PCT, NO,
CRP, and ADA in G1 and G2 comparisons AT (Table 2).
The AUC, cut-off values, sensitivity, specificity, and
Youden’s index of the parameters were identified using
ROC analysis for pretreatment of Babesia ovis-infected
sheep (Table 3). ROC curve analysis showed that CRP had
the highest AUC (AUC 0.86) compared with PCT (AUC
0.80), ADA (AUC 0.78), and NO (AUC 0.74) (Figure and
Table 3).
3.4. Hematological findings
When blood parameters were examined, it was found that BT
levels of WBC, LYM, RBC, PCV, and HGB were statistically
significant when compared to healthy sheep, and that WBC
and LYM were high and RBC, HGB, and PCV were low in
sheep with babesiosis (Table 4). When comparing the BT and
AT blood parameters, statistical significance was determined
only in MCH in G1 animals, and in monocyte, neutrophil,
RBC, PCV, and HGB levels in G2. When the AT results of
G1 and G2 were compared, no statistical significance was
determined for any blood parameters (Table 5).

Table 1. PCT, CRP, NO levels, and ADA activity in the control group and all sheep having babesiosis for the BT period (mean ± SEM).
Parameters

Control
(n = 15)

BT babesiosis
(n = 30)

P

PCT (ng/mL)

0.49 ± 0.04

1.72 ± 0.34

P < 0.01

CRP (µg/mL)

49.46 ± 4.57

101.42 ± 11.73

P < 0.001

NO (µmol/L)

8.15 ± 0.63

15.77 ± 2.75

P < 0.01

ADA (IU/L)

9.34 ± 1.19

13.92 ± 0.88

P < 0.01

The control group and all sheep having babesiosis were compared before treatment
(BT). Statistical significance was accepted as P < 0.05.
Table 2. Before-treatment (BT) and after-treatment (AT) PCT, CRP, and NO levels, and ADA activity of G1 and G2.
G1

G2

AT G1–G2

Parameters

BT (n = 15)

AT (n = 15)

BT (n = 15)

AT (n = 15)

P

PCT (ng/mL)

1.98 ± 0.55

0.53 ± 0.08*

1.45 ± 0.42

0.57 ± 0.11*

P > 0.05

CRP (µg/mL)

101.91 ± 17.72

54.01 ± 6.48*

100.92 ± 16.01

53.66 ± 3.37**

P > 0.05

NO (µmol/L)

17.58 ± 4.45

4.28 ± 0.89**

13.97 ± 3.31

2.19 ± 0.20**

P > 0.05

ADA (IU/L)

16.01 ± 1.10

9.95 ± 1.40**

11.84 ± 1.16

8.16 ± 1.47

P > 0.05

G1 and G2 were compared BT and AT among themselves. For statistical significance, * P < 0.05, ** P < 0.01. In addition,
P-values for comparing the AT values of G1 and G2 are given in the rightmost column of the table.
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Table 3. AUC, sensitivity, specificity, cut-off values of PCT, CRP, NO, ADA for pretreatment Babesia ovis-infected sheep.
Parameters

AUC 95% confidence
interval

P

Cut-off
value

Sensitivity

Specificity

Youden’s
index

PCT (ng/mL)

0.80 (0.65–0.94)

<0.01

0.48

0.93

0.60

0.53

CRP (µg/mL)

0.86 (0.75–0.97)

<0.01

71.0

0.63

0.93

0.57

NO (µmol/L)

0.74 (0.59–0.89)

<0.001

9.93

0.87

0.67

0.53

ADA (IU/L)

0.78 (0.63–0.92)

<0.01

13.47

0.70

0.87

0.57

Youden’s index was used to choose an appropriate cut-off value.

Figure. ROC curves of the diagnostic performance of PCT, CRP, NO, and ADA for pretreatment Babesia ovis-infected sheep.

3.5. Biochemical findings
When biochemical data were evaluated, it was found that
the differences between ALP, total bilirubin, albumin, and
glucose levels of the sheep with babesiosis and the healthy
sheep were statistically significant (Table 6). There was a
decrease in ALP and albumin levels and an increase in
T-bilurubin levels in sheep with bebesiosis. In BT and
AT comparisons, a statistically significant decrease was
determined for albumin in the G1 group, and a significant
increase in BUN in G2. When G1 and G2 were compared
for AT, a statistically significant increase was determined
for T-bilurubin and D-bilurubin in G2, and a decrease
in total protein levels in the same group compared to G1
(Table 7).

4. Discussion
B. ovis, which is commonly found in Turkey, is highly
pathogenic in sheep and is characterized by fever, anemia,
icterus, and hemoglobinuria. In our study, the high fever,
anorexia, icterus, and hemoglobinuria which were seen
in sheep with bebesiosis are similar to clinical findings in
previous studies (2,21).
The fact that the levels of RBC, PCV, and HGB in
infected animals are significantly reduced compared
to healthy animals shows compatibility with previous
studies (22–24). The decrease of these parameters reveals
the presence of anemia, which occurs as the result of
destruction caused by a parasite on RBC. Morphological
classification of the anemia can be done according to MCV
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Table 4. Hematological parameters in the control group and all sheep having babesiosis for
the BT period (mean ± SEM).
Hematologic
parameters

Control
(n = 15)

BT babesiosis
(n = 30)

P

WBC (×103/µL)

11.07 ± 0.62

18.54 ± 1.97

P <0.01

LYM (×10 /µL)

3.46 ± 0.53

11.10 ± 2.15

P <0.05

MON (×10 /µL)

0.63 ± 0.10

0.44 ± 0.07

P >0.05

NEU (×10 /µL)

6.68 ± 0.65

6.60 ± 0.77

P >0.05

EOS (×10 /µL)

0.27 ± 0.07

0.39 ± 0.08

P >0.05

RBC (×10 /µL)

9.95 ± 0.17

8.87 ± 0.32

P <0.05

MCV (fl)

28.96 ± 0.43

28.39 ± 0.45

P >0.05

PCV (%)

28.50 ± 0.42

24.86 ± 0.83

P <0.01

MCH (pg)

10.24 ± 0.16

10.07 ± 0.14

P >0.05

MCHC (g/dL)

35.56 ± 0.82

35.81 ± 0.54

P >0.05

RDW (%)

14.79 ± 1.00

14.15 ± 0.67

P >0.05

HGB (g/dL)

10.22 ± 0.21

8.91 ± 0.31

P <0.01

3

3

3

3

6

The control group and all sheep having babesiosis at BT were compared. Statistical significance was accepted as P <0.05.
Table 5. BT and AT hematologic parameters of G1 and G2.
Hematologic
parameters

G1
BT (n = 15)

AT (n = 15)

BT (n = 15)

AT (n = 15)

P

WBC (×103/µL)

15.55 ± 2.21

14.66 ± 1.92

21.53 ± 3.14

17.33 ± 1.98

P >0.05

LYM (×103/µL)

8.04 ± 2.52

5.32 ± 1.25

14.16 ± 3.38

5.48 ± 1.16

P >0.05

MON (×103/µL)

0.59 ± 0.11

0.58 ± 0.08

0.28 ± 0.05

0.48 ± 0.08*

P >0.05

NEU (×10 /µL)

6.62 ± 0.89

8.16 ± 1.62

6.57 ± 1.30

10.96 ± 2.00*

P >0.05

EOS (×10 /µL)

0.30 ± 0.082

0.54 ± 0.15

0.49 ± 0.13

0.36 ± 0.066

P >0.05

RBC (×10 /µL)

8.35 ± 0.49

8.41 ± 0.42

9.38 ± 0.39

7.90 ± 0.46*

P >0.05

MCV (fl)

29.13 ± 0.73

26.97 ± 1.87

27.65 ± 0.47

29.02 ± 0.61

P >0.05

PCV (%)

23.92 ± 1.33

24.10 ± 1.21

25.81 ± 0.99

22.54 ± 1.18*

P >0.05

MCH (pg)

10.41 ± 0.13

10.01 ± 0.18*

9.73 ± 0.22

9.87 ± 0.21

P >0.05

MCHC (g/dL)

36.16 ± 0.80

35.12 ± 0.57

35.45 ± 0.75

34.33 ± 0.72

P >0.05

RDW (%)

15.06 ± 1.27

15.63 ± 1.32

13.25 ± 0.33

13.39 ± 0.45

P >0.05

HGB (g/dL)

8.68 ± 0.52

8.45 ± 0.44

9.13 ± 0.35

7.79 ± 0.49*

P >0.05

3

3

6

G2

AT G1–G2

G1 and G2 were compared as BT and AT among themselves. For statistical significance, *: P <0.05, **: P <0.01. In addition, P values for comparing the AT values of G1 and G2 are given in the rightmost column of the table.

and MCHC (25). MCV and MCHC values in the control
and the babesiosis group were close to each other and of the
reference intervals (26). This situation can be considered
as the type of normocytic-normochromic anemia in sheep
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known as nonregenerative anemia (25). Animals with
nonregenerative anemia have normal RDW values as
long as they have no significant dyserethropoiesis (25).
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Table 6. Biochemical parameters in the control group and in all sheep having babesiosis for the
BT period (mean ± SEM).
Biochemical
parameters

Control
(n =15)

BT babesiosis
(n = 30)

P

ALP (U/L)

82.59 ± 5.64

74.00 ± 9.48

P <0.05

BUN (mg/dL)

30.29 ± 7.12

30.22 ± 4.03

P >0.05

Total bilurubin (mg/dL)

0.03 ± 0.01

0.16 ± 0.04

P ≤0.01

Direct bilurubin (mg/dL)

0.02 ± 0.01

0.1 ± 0.03

P >0.05

Total protein (g/dL)

7.61 ± 0.17

7.20 ± 0.22

P >0.05

Albumin (g/dL)

2.48 ± 0.07

2.20 ± 0.05

P <0.01

CK (U/L)

159.18 ± 43.66

268.92 ± 73.17

P >0.05

Glucose (mg/dL)

55.69 ± 3.60

45.19 ± 2.45

P ≤0.01

Creatine (mg/dL)

1.26 ± 0.12

1.11 ± 0.06

P >0.05

The control group and all sheep having babesiosis BT were compared. Statistical significance
was accepted as P <0.05.
Table 7. BT and AT biochemical parameters of G1 and G2.
Biochemical
parameters

G1

G2

AT G1–G2

BT (n = 15)

AT (n = 15)

BT (n = 15)

AT (n = 15)

P

ALP (U/L)

82.00 ± 13.54

72.36 ± 11.19

65.33 ± 13.36

72.94 ± 11.56

P >0.05

BUN (mg/dL)

34.22 ± 6.12

36.65 ± 9.06

25.88 ± 5.12

47.66 ± 8.63*

P >0.05

Total bilurubin (mg/d)

0.17 ± 0.05

0.09 ± 0.05

0.16 ± 0.05

0.27 ± 0.08

P <0.01

Direct bilurubin (mg/d)

0.14 ± .06

0.05 ± 0.01

0.06 ± 0.02

0.14 ± 0.04

P <0.05

Total protein (g/dL)

7.11 ± 0.23

7.53 ± 0.18

7.29 ± 0.40

6.88 ± 0.22

P <0.05

Albumin (g/dL)

2.13 ± 0.07

2.05 ± 0.09*

2.28 ± 0.08

2.11 ± 0.07

P >0.05

CK (U/L)

185.70 ± 64.35

565.82 ± 266.46

359.08 ± 134.23

782.84 ± 300.61

P >0.05

Glucose (mg/dL)

48.00 ± 2.18

45.06 ± 4.51

42.15 ± 4.47

57.46 ± 4.38

P >0.05

Creatine (mg/dL)

1.02 ± 0.10

0.88 ± 0.08

1.20 ± 0.07

0.99 ± 0.08

P >0.05

G1 and G2 were compared as BT and AT among themselves. For statistical significance, *: P <0.05, **: P <0.01. In addition, P values for
comparing the AT values of G1 and G2 are given in the rightmost column of the table.

The type of normocytic–normochromic anemia we have
determined here is compatible with that in previous studies
on cattle (27) and sheep (2) with babesiosis. The increase
in the number of WBCs in animals with babesiosis is
consistent with the findings of Esmaeilnejad et al. (22),
while differing from the study by Rahbari et al. (23).
The WBC increase can be attributed to lymphocytosisinduced immune enhancement. NSAIDs (nonsteroidal
anti-inflamatory drugs) may lead to some hematologic
side effects such as slowing of hemostasis, prolongation of

bleeding, and rarely aplastic anemia, thrombocytopenia,
agranulocytosis, and blood dyscrasias (28). The decrease
in RBC, PCV, and HGB and increase in monocyte and
neutrophil counts in G2 after treatment may be due to
flunixin meglumine, an NSAID drug.
In sheep with babesiosis, the increase in T-bilirubin
is consistent with findings in the study by Sevinç et al. (2),
and the decrease in ALP and albumin are similar to those
reported by Yeruham et al. (29). Elevated T-bilurubin
may result from excessive erythrocyte degradation and
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liver damage (2), and decreased albumin level can be
due to liver function disorders, renal insufficiency, and
anorexia resulting from high body temperature (22). High
T-bilurubin levels observed in our study may be related
to erythrocyte degradation and decreased albumin; high
glucose levels, to anorexia. Low ALP levels have been
reported to have an assocciation with severe anemia,
deficiency of vitamin C, B12, zinc, iron, or magnesium,
malnutrition, and hypothyroidism (30,31). In our study,
we think that low ALP levels were caused by the anemia.
In a study conducted on goats (32), it was determined that
flunixin meglumine caused an increase in BUN, creatine,
ALP, GGT, and AST levels. The increase in BUN level in G2
after treatment and the decrease in total protein level and
increases in T-bilirubin and D-bilirubin after treatment
when G1 and G2 were compared may be due to the effect
of flunixin megluminine, as mentioned by Safarchi et al.
(32). Flunixin meglumin has been reported to increase
CK activity in a single intramuscular dose application (33)
because it is a highly irritating agent. The increase in CK
in G2 after treatment, although not statistically significant,
may be caused by flunixin meglumin administered IM.
CRP increases after trauma, inflammation, and tissue
damage, especially in bacterial infections (34). CRP is a
nonspecific biochemical marker, although very useful in
inflammation (35). CRP has been reported to increase in
dogs naturally infected with Babesia canis (36,37). In our
study, we believe that the increase in the levels of CRP in
sheep with babesiosis sheep and their return to normal after
treatment may be important in monitoring the disease.
PCT is used in the diagnosis of sepsis in human
medicine; it has been expressed that PCT is a good
predictor of inflammatory response parameters such as
body temperature, CRP, and leukocyte count. In addition,
PCT is used in the diagnosis of inflammatory diseases, and
in the prognosis and monitoring of response to treatment.
Although PCT is identified as a marker of bacterial
infections, it is also increased in acute malaria and fungal
infections (15). Babesiosis is similar in many respects to
human falciparum malaria (38). Babesiosis is characterized
by malaria-like fever, hemolysis, and hemoglobinuria (39).
Increased serum PCT concentrations have been reported in
patients with Plasmodium falciparum malaria (10,40,41). In
a study on dogs infected with Babesia canis, it was stated that
the PCT level was significantly increased in diseased animals
compared to healthy animals (13). In our study, it was also
found that in sheep with babesiosis, the PCT level was
significantly increased when compared to that of the healthy
sheep. There was a significant difference between BT and AT
PCT levels in both G1 and G2, and PCT levels appeared to
be decreased in treated animals. This can provide us with
important data in assessing the prognosis of the disease. It
has been reported that PCT production is not significantly
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attenuated by steroidal and nonsteroidal antiinflammatory
drugs (5). In our study, the AT values of flunixin meglumine,
a nonsteroidal antiinflammatory drug used in G2, do not
seem to have significant differences when compared to the
values of G1.
The enzyme ADA increases due to stimulation of
cellular immunity (16). Its most important physiological
role is related to the differentiation and proliferation of
lymphocytes (42). Increased serum ADA activity has been
reported in various diseases such as leukosis (43), hepatic
diseases (44), theileriasis (16), and babesiosis (17,45) in
cattle. In our study, it was determined that ADA activity was
increased in sheep with babesiosis in the BT period, and
decreased to normal levels in the AT period. The increase in
ADA in sheep with babesiosis during the BT period may be
attributed to stimulation of lymphocyte-mediated immunity,
the erythrocytic destruction caused by the parasite, and/or
phagocytic activity of macrophages.
LPS and IFN-γ-stimulated macrophages produce
cytostatic and/or cytotoxic effects against bacteria, parasites,
and tumor cells by producing a large amount of NO (19).
It has been suggested during in vitro experiments that NO
reduces B. Bovis’s viability and B. bovis merozoites stimulate
NO production through monocytes/macrophages in the
presence of IFN-γ and TNF-α (46). Babesia ovis increases the
level of nitrite/nitrate, which is the oxidation product of NO,
in sheep (47) and goats (48). In our study, it was determined
that NO levels increased in sheep having babesiosis during
the BT period and decreased in the AT period. This increase,
seen in sheep having babesiosis during the BT period, may
be due to Babesia agents stimulating NO production in sheep
macrophages and increasing NO release. The reduction of
NO levels in the AT period may also be attributed to the
reduction of NO stimulation of sheep macrophages by
parasitic agents as a result of the efficacy of the treatment.
When the ROC curve characteristics of CRP and PCT
were compared to those of ADA and NO, the AUC of CRP
appeared superior to that of PCT, whereas the AUC of ADA
and NO appeared inferior to that of PCT, suggesting that
CRP provided the most accurate diagnostic performance for
pretreatment Babesia ovis-infected sheep. In one study (49),
the AUC value of PCT for severe P. Falciparum malaria was
found to be 0.78, and the AUC value we obtained is close to
this value.
In conclusion, the PCT, CRP, and NO levels and ADA
activity in sheep with babesiosis are useful parameters
to be measured and evaluated together with the clinical
examination for the diagnosis and prognosis of the disease.
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